Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.

× No keyword cloud information.

20 in total

1. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway.

Authors: Chun-Yan Wu; Zhi-Han Tang; Lu Jiang; Xue-Fei Li; Zhi-Sheng Jiang; Lu-Shan Liu
Journal: Mol Cell Biochem Date: 2011-08-17 Impact factor: 3.396

2. Differential pro-inflammatory responses of TNF-α receptors (TNFR1 and TNFR2) on LOX-1 signalling.

Authors: Albina Arjuman; Nimai C Chandra
Journal: Mol Biol Rep Date: 2014-11-23 Impact factor: 2.316

Review 3. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors: Juan M Saavedra
Journal: Clin Sci (Lond) Date: 2012-11 Impact factor: 6.124

Review 4. Vascular Endothelial Cells and Innate Immunity.

Authors: Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal: Arterioscler Thromb Vasc Biol Date: 2020-05-27 Impact factor: 8.311

5. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.

Authors: Tao Pang; Julius Benicky; Juan Wang; Martina Orecna; Enrique Sanchez-Lemus; Juan M Saavedra
Journal: J Hypertens Date: 2012-01 Impact factor: 4.844

6. Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment.

Authors: Xiaoyue Pan
Journal: Adv Exp Med Biol Date: 2022 Impact factor: 2.622

7. Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes.

Authors: Ignacio M Larrayoz; Tao Pang; Julius Benicky; Jaroslav Pavel; Enrique Sánchez-Lemus; Juan M Saavedra
Journal: J Hypertens Date: 2009-12 Impact factor: 4.844

8. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.

Authors: Bijoy Chellan; Catherine A Reardon; Godfrey S Getz; Marion A Hofmann Bowman
Journal: Arterioscler Thromb Vasc Biol Date: 2016-04-14 Impact factor: 8.311

9. Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity.

Authors: Halit Eren Taskin; Ahmet Kocael; Pinar Kocael; Kagan Zengin; Muzaffer Al; Volkan Sozer; J N Buchwald; T W McGlennon; Hafize Uzun
Journal: Surg Endosc Date: 2022-01-19 Impact factor: 4.584

10. Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.

Authors: Carmine Di Rienzo; Emanuela Jacchetti; Francesco Cardarelli; Ranieri Bizzarri; Fabio Beltram; Marco Cecchini
Journal: Sci Rep Date: 2013-01-25 Impact factor: 4.379